GlassScriptPhysician profile
Thorp J Davis
NPI 1992732218
$2,965,777.98
in general payments reported to CMS, 2019-2025
7 companies · $6,820 in 2025
The $6,820 reported for 2025 was more than what 84% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2.5M · 2021: $311K · 2022: $29K · 2023: $78K · 2025: $6,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $84K · Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $84,005.40 |
| Food and Beverage | $374.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,541,915.80 | 2020 | |
| Medtronic, INC. | $422,248.10 | 2021-2025 | Ellipsys Vascular Access System |
| Fortis Surgical, LLC | $1,200.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $276.35 | 2023-2025 | Comprehensive Shoulder System |
| Smith+Nephew, INC. | $98.36 | 2023 | Bone Anchors With Arthroscopic Delivery System |
| Arthrex, INC. | $39.37 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,006,332.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thorp Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.